Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Nodule | 11 | 2024 | 764 | 2.920 |
Why?
|
Thyroid Neoplasms | 18 | 2024 | 2332 | 2.210 |
Why?
|
Watchful Waiting | 2 | 2024 | 491 | 0.790 |
Why?
|
Carcinoma, Neuroendocrine | 5 | 2023 | 339 | 0.620 |
Why?
|
Thyroidectomy | 2 | 2022 | 907 | 0.600 |
Why?
|
Biopsy, Fine-Needle | 7 | 2024 | 1118 | 0.560 |
Why?
|
Thyroid Gland | 2 | 2020 | 1168 | 0.530 |
Why?
|
Ultrasonography | 7 | 2024 | 5970 | 0.460 |
Why?
|
Patient Preference | 1 | 2020 | 926 | 0.410 |
Why?
|
Thyrotoxicosis | 1 | 2022 | 85 | 0.190 |
Why?
|
Retrospective Studies | 17 | 2024 | 80575 | 0.180 |
Why?
|
Graves Disease | 1 | 2022 | 238 | 0.170 |
Why?
|
Graves Ophthalmopathy | 1 | 2022 | 133 | 0.170 |
Why?
|
Oxyphil Cells | 1 | 2019 | 56 | 0.160 |
Why?
|
Pheochromocytoma | 1 | 2021 | 328 | 0.160 |
Why?
|
Hashimoto Disease | 1 | 2019 | 105 | 0.150 |
Why?
|
Thyrotropin | 2 | 2022 | 835 | 0.150 |
Why?
|
Calcitonin | 1 | 2019 | 329 | 0.150 |
Why?
|
Carcinoma, Papillary | 1 | 2023 | 784 | 0.150 |
Why?
|
Ki-67 Antigen | 3 | 2022 | 629 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 732 | 0.120 |
Why?
|
Postoperative Period | 1 | 2020 | 1813 | 0.120 |
Why?
|
Mutation | 6 | 2023 | 30044 | 0.120 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2052 | 0.120 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2914 | 0.120 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14665 | 0.110 |
Why?
|
Middle Aged | 14 | 2024 | 220774 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1212 | 0.110 |
Why?
|
Hypothyroidism | 1 | 2017 | 667 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2453 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2060 | 0.100 |
Why?
|
Humans | 25 | 2024 | 761326 | 0.100 |
Why?
|
Genomics | 2 | 2024 | 5817 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2859 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2328 | 0.100 |
Why?
|
Preoperative Care | 1 | 2020 | 2242 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3469 | 0.090 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15262 | 0.090 |
Why?
|
Male | 16 | 2024 | 360621 | 0.090 |
Why?
|
Health Surveys | 1 | 2020 | 4059 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.080 |
Why?
|
Female | 14 | 2024 | 392485 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39108 | 0.080 |
Why?
|
Adult | 11 | 2024 | 221122 | 0.070 |
Why?
|
Necrosis | 2 | 2022 | 1605 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3611 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4423 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9275 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2021 | 10431 | 0.060 |
Why?
|
Risk Assessment | 3 | 2022 | 23981 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6332 | 0.060 |
Why?
|
Aged | 9 | 2024 | 169179 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 12949 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7852 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9414 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8527 | 0.050 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2022 | 34 | 0.050 |
Why?
|
Receptors, Thyrotropin | 1 | 2022 | 45 | 0.050 |
Why?
|
New South Wales | 1 | 2021 | 69 | 0.050 |
Why?
|
Arginine-tRNA Ligase | 1 | 2021 | 2 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2023 | 225 | 0.050 |
Why?
|
Mitotic Index | 1 | 2021 | 161 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17872 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 54405 | 0.040 |
Why?
|
Biological Assay | 1 | 2022 | 626 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 294 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 414 | 0.040 |
Why?
|
Prognosis | 3 | 2023 | 29588 | 0.040 |
Why?
|
Cohort Studies | 4 | 2021 | 41440 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2019 | 956 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 74152 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2019 | 404 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2019 | 328 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1004 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15647 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58946 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3420 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2021 | 1738 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20092 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5247 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 787 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 59196 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15499 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2123 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1858 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2017 | 751 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3122 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3572 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1780 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2724 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6768 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3538 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12982 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5794 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9605 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88305 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21336 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7389 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42251 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23427 | 0.010 |
Why?
|
United States | 1 | 2021 | 72317 | 0.010 |
Why?
|
Child | 1 | 2021 | 80156 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64645 | 0.010 |
Why?
|
Concepts
(103)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_